Male breast cancer (MBC) is a rare disease accounting for less than 1% of all breast cancer cases and it was previously shown that nearly 90% of MBC arising in BRCA mutation carriers are found to harbor a BRCA2 mutation [48]. The gene discussed is BRCA2; the disease is breast carcinoma.